Skip to main content
Expensive brand-name medications lead drug spending

An analysis by Blue Cross Blue Shield found that even though only 18% of total prescriptions filled were for expensive branded drugs, they accounted for 78% of total spending since 2010. The biggest costs came from Humira, Remicade and Enbrel.

Full Story: